Goldenwell Biotech, Inc. GWLL

What this company does

Effective July 20, 2020, the Company entered into an Exclusive License Agreement with Australian Trefoil Health Technologies Pty Ltd, pursuant to which the Company has licensed from Australian Trefoil the technology and packaging designs underlying the Sugar Master and DNA Repair products, and other products of the Company. Bovine cardiac vascular active peptide is a protein peptide of vascular homology made from healthy and fresh bovine cardiac vascular tissues as raw materials. Type II collagen peptide is prepared from bovine or pig cartilage bones by hot water extraction, and then it is enzymolyzed by neutral protease, protamex, acidic protease and pepsin, through purification, ultrafiltration and other extraction process to structural polypeptide in a freeze-dried powder form peptide with molecular weight of 8000 daltons. The company relies on a combination of trademark laws, trade secrets, confidentiality provisions and other contractual provisions to protect its proprietary rights, which are primarily its brand names, product designs and marks.

Written from the business description in Goldenwell Biotech, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 1 July 2026. Every sentence was checked against that document before publication.